Organization:Society of Infectious Diseases Pharmacists

From HandWiki
Short description: Professional medical association
Society of Infectious Diseases Pharmacists
SIDP Logo 2019.png
AbbreviationSIDP
Formation1990
TypeProfessional Association
HeadquartersGeneva, IL
Location
  • United States
Membership (2023)
2000+
President
Sam Aitken, PharmD, MPH, BCIDP
President-Elect
Erin McCreary, PharmD, BCPS, BCIDP
Past President
Melissa Johnson, PharmD, MHS, AAHIVP
Websitehttps://www.sidp.org/

The Society of Infectious Diseases Pharmacists (SIDP) is a non-profit association of pharmacists and other allied health professionals who specialize in infectious diseases and antimicrobial stewardship.[1] According to the Board of Pharmaceutical Specialties, clinical pharmacists specializing in infectious diseases are trained in the use of microbiology and pharmacology to develop, implement, and monitor drug regimens that incorporate the pharmacodynamics and pharmacokinetics of antimicrobials for patients.[2]

Headquartered in Geneva, Illinois, the organization was founded in 1990 and has 2,000+ members who are involved in patient care, research, teaching, pharmaceutical industry, and government. Its stated mission is to "Advance infectious diseases pharmacy through collaboration, research, and education and lead antimicrobial stewardship to optimize the care of patients with infections in every practice setting."[1] In order to achieve its mission, SIDP collaborates with several other healthcare organizations including the Infectious Diseases Society of America (IDSA), American College of Clinical Pharmacy (ACCP), Society for Healthcare Epidemiology of America (SHEA) and American Society for Microbiology (ASM), American Society of Health-System Pharmacists (ASHP), Clinical and Laboratory Standards Institute (CLSI), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), European Society of Clinical Pharmacy (ESCP), Making a Difference in Infectious Diseases (MAD-ID), and International Pharmaceutical Federation (FIP).[1]

Advocacy for Antimicrobial Stewardship

The World Health Organization[3] and Centers for Disease Control and Prevention[4] have identified antimicrobial resistance as one of the biggest public health threats of our time. SIDP has identified promoting the appropriate use of antimicrobials and decreasing resistance as priorities for the organization. In 2003, SIDP warned of an "exponential increase in resistance" by antibiotic-resistant bacteria.[5] In 2009, SIDP supported a study that identified antibiotics which appeared less likely to lead to antibiotic resistance.[6] The SIDP Policy and Government Affairs Committee (PGA) focuses efforts on legislative and regulatory matters related to infectious diseases therapeutics and antimicrobial use and resistance. The SIDP Public Outreach Committee develops partnerships, activities, and programs that educate the general public on the safe and effective use of antimicrobials and pharmacists’ roles in antimicrobial stewardship. The SIDP Diversity, Equity, and Inclusion (DEI) Committee is committed to creating and sustaining an inclusive and welcoming society and improving the representation of minorities in its membership, leadership, and profession. SIDP advocates to government and private entities on key issues and educates the public, together with strategic partners, to enact positive change.

Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB)

In January 2019, the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) convened to respond to the charge of the United States Secretary of Health and Human Services, Alex Azar, to gather public input on combating antimicrobial resistance.[7] Former SIDP president, Kerry LaPlante presented public comments stating the need to prioritize accelerating research and development of new antimicrobials through innovative funding mechanisms, protecting the supply of existing drugs, and developing strategies to mitigate anti-infective shortages. LaPlante said, "Together, we scramble to concoct mixtures of antibiotics, using in vitro data, hoping to override resistance and hoping for synergy to save our dying patients. Many of these patients have already endured and overcome months of chemotherapy, only to find themselves kicked down and fighting for their lives – again."[8] In September 2020, Elizabeth Dodds-Ashley, former SIDP President, was appointed as a designated representative to PACCARB.[9]

U.S. Government Antimicrobial Resistance (AMR) Challenge

The U.S. Government Antimicrobial Resistance (AMR) Challenge is a global initiative, launched in 2018, that charges pharmaceutical and health insurance companies, food animal producers and purchasers, medical professionals, government health officials, and other industry leaders from around the world to work together to address antibiotic resistance. The AMR Challenge is a way for organizations to make formal commitments to further the progress against antimicrobial resistance.[10][11]

SIDP has submitted a commitment to the AMR Challenge to promote appropriate antimicrobial use.[10] As part of this commitment, in 2019, SIDP collaborated with the Centers for Disease Control and Prevention and the American Society of Health-System Pharmacists to develop educational materials on how pharmacists can improve antimicrobial use.[12] Healthcare providers can submit a formal commitment to adopt these practices.[13][14]

According to Secretary Azar, nearly 350 national and international organizations have committed to the AMR Challenge, including Infectious Diseases Society of America, American Academy of Emergency Medicine, American Cancer Society, Pew Charitable Trusts, and the U.S. Department of Defense[15][10]

Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act of 2023 (PASTEUR Act of 2023)

There were an estimated 4.95 million deaths associated with bacterial AMR in 2019, including 1.27 million deaths attributable to bacterial AMR.[16] The purpose of the PASTEUR Act of 2023 is to establish a program to develop antimicrobial targeting the difficult to treat bacterial and fungal pathogens and most threatening infections, and for other purposes.[17] SIDP is one of 237 organizations that urged lawmakers to advance the PASTEUR Act in 2023.[17]

Legislative Support

On June 4, 2019, the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act S. 1712 was introduced by United States Senators Johnny Isakson (R-GA) and Bob Casey (D-PA). The DISARM Act would promote antibiotic research and development and preserve existing antibiotics by improving Medicare reimbursement for antibiotics and promoting their appropriate use.[18] SIDP joined other medical organizations such as Infectious Diseases Society of America, American Academy of Allergy, Asthma and Immunology and American Society for Microbiology in signing a letter of support for the DISARM Act.[19]

Similarly, SIDP and other infectious diseases organizations have signed a letter of support for the Strategies to Address Antimicrobial Resistance Act (STAAR) which is aimed at strengthening existing federal infrastructure for surveillance, data collection, and research efforts.[20]

Since November 2022, SIDP has signed onto 7 letters advocating for varied issues related to legislature, antibiotic resistance, and funding. The sponsoring organizations and focus areas of the letters are summarized in the table below:

Focus Area Sponsoring Organization Month Letter Signed
Bio-Preparedness Workforce Pilot Program[21] IDSA November 2022
Senate HELP Committee: National program to closely monitor antibiotic use in human and non-human settings Natural Resources Defense Council February 2023
Joint Pharmacy Org Post-PHE Priorities ASHP February 2023
PASTEUR Act[17] S-FAR February 2023
FY24 Public Health and Bio Pilot LRP IDSA, ASM, HIVMA March 2023
Bio-Preparedness Workforce Pilot Program[21] IDSA May 2023
FDA Breakpoints meeting follow-up ASM June 2023

Publications and Activities

Other activities SIDP engages in include clinical guidance, position statements, and education. SIDP has endorsed guidance for necessary skills for antimicrobial stewardship leaders,[22] the essential role of pharmacists in antimicrobial stewardship,[23] management of COVID-19,[24] and the optimal use of polymyxins.[25] In addition, SIDP has published position statements promoting the appropriate use of antimicrobials in various settings such as agricultural applications[26] and ambulatory care settings.[27] For all publications, visit: https://sidp.org/SIDP-Publications

At the close of 2019 it was announced that SIDP would become a partner in IDWeek.[28][29][30] IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS), and the Society of Infectious Diseases Pharmacists (SIDP). As a partner society, SIDP has a representative on the official planning committee who serves a 3-year term. The goal of SIDP in our role as a partner organization of IDWeek is to bring experts together in research and practice to present and network at the annual meeting. The annual SIDP business meeting and reception are currently held in conjunction with IDWeek.

Educational Programming

SIDP provides education activities on infectious diseases pharmacotherapy and antimicrobial stewardship through live and enduring webinar programing, home study content, and live programming at the annual SIDP business meeting (held in conjunction with IDWeek.[31] Examples of programming include:  on-demand modules, live webinars and symposia, podcasts, journal clubs, and an antimicrobial stewardship certificate program. Though primarily targeted towards pharmacists, many educational activities are also accredited for other healthcare disciplines. Additionally, SIDP funds education grants for initiatives that provide public education or support novel training mechanisms for healthcare professionals.[32] SIDP is an ACPE-accredited CE providers and BPS-approved  for BCIDP recertification credits.[33] Most activities are free or available at a reduced cost for SIDP members.

Public Outreach

As part of SIDP’s commitment to educating the public and healthcare providers about the role of ID pharmacists and the optimal use of antimicrobials, an Antimicrobial Stewardship Advocacy Toolkit was developed to guide healthcare providers in improving antimicrobial use within their own healthcare systems.[34] The toolkit is available on the SIDP website as a free resource and includes information such as methods to demonstrate commitment, posters with key action items for pharmacists, guidance for how to implement and promote proper antibiotic disposal, recommendations for raising public awareness of antimicrobial stewardship efforts, and educational handouts focused on antimicrobial stewardship and the CDC’s One Health Initiative. Other educational resources created for the public include an antimicrobial stewardship curriculum for high school students, information about the annual U.S. and World Antibiotic Awareness Week, and handouts on the safety and efficacy of COVID-19 vaccines.

In 2022, the organization began promoting an Infectious Diseases Pharmacist Advocacy Day through social media on the first Thursday of every month. SIDP also hosts Infectious Diseases Pharmacists Day annually on May 22nd to celebrate the essential work infectious diseases pharmacists perform each day to combat antimicrobial resistance and optimize the care of patients. The inaugural Infectious Diseases Pharmacists Day took place on May 22nd, 2021. Given the important role infectious diseases pharmacists played during the first year of the COVID-19 pandemic, the theme was “Essential COVID-19 Healthcare Workers.” Dates and themes for all Infectious Diseases Pharmacists Days are listed below.

Year ID Pharmacists Day Theme
2021 Essential COVID-19 Healthcare Workers
2022 Deprescribing Antibiotics in COVID-19
2023 Reaching Beyond

Breakpoints- The SIDP Podcast

Launched July 2019, Breakpoints is the official podcast of SIDP. Episodes are released monthly and feature thought leaders in infectious diseases discussing contemporary topics and clinical controversies. Listeners can tune in from Apple Podcasts, Stitcher, Spotify, Overcast, and other popular podcast hosting websites.

References

  1. ↑ 1.0 1.1 1.2 "SIDP - About". https://sidp.org/About. 
  2. ↑ "Infectious Diseases Pharmacy". https://www.bpsweb.org/bps-specialties/infectious-diseases-pharmacy/. 
  3. ↑ "World Health Organization". https://www.who.int/antimicrobial-resistance/publications/global-action-plan/en/. 
  4. ↑ "CDC-Antimicrobial Resistance". https://www.cdc.gov/drugresistance/index.html. 
  5. ↑ Bob Groves, "Still searching for Kryptonite: Superbugs' march prompts expansion of a testing and database program", The Record (June 30, 2003), p. F-1.
  6. ↑ Alex Paul, "Hospital cuts MRSA infection", Albany Democrat-Herald (December 25, 2009), p. 3.
  7. ↑ "DHHS PACCARB Meeting". 2018-10-17. https://www.hhs.gov/ash/advisory-committees/paccarb/meetings/upcoming-meetings/january-30-2019-public-meeting/index.html. 
  8. ↑ "PACCARB Meeting Notes". https://www.hhs.gov/sites/default/files/paccarb-meeting-summary-jan-30-31-2019.pdf. 
  9. ↑ Health (ASH), Assistant Secretary for (2020-09-09). "Designated Representative: Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS" (in en). https://www.hhs.gov/ash/advisory-committees/paccarb/membership/designated-representative-elizabeth-dodds-ashley/index.html. 
  10. ↑ 10.0 10.1 10.2 "CDC AMR Challenge". https://www.cdc.gov/drugresistance/intl-activities/amr-challenge.html. 
  11. ↑ "Pharmacy Times-AMR Challenge". https://www.pharmacytimes.com/news/us-leads-fight-against-antibiotic-resistance-intensifies-with-worldwide-amr-challenge. 
  12. ↑ "CDC Appropriate Antibiotic Use". 2019-08-29. https://www.cdc.gov/antibiotic-use/community/materials-references/print-materials/index.html. 
  13. ↑ "SIDP - Stewardship Advocacy Toolkit". https://www.sidp.org/AMSToolkit. 
  14. ↑ "Join the AMR Challenge" (in en-us). 2021-02-26. https://www.cdc.gov/drugresistance/intl-activities/amr-challenge.html. 
  15. ↑ "Secretary Azar's Remarks on AMR Challenge at United Nations General Assembly". 2019-09-24. https://www.hhs.gov/about/leadership/secretary/speeches/2019-speeches/remarks-one-year-anniversary-antimicrobial-resistance-challenge.html. 
  16. ↑ Murray, Christopher J L; Ikuta, Kevin Shunji; Sharara, Fablina; Swetschinski, Lucien; Robles Aguilar, Gisela; Gray, Authia; Han, Chieh; Bisignano, Catherine et al. (February 2022). "Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis". The Lancet 399 (10325): 629–655. doi:10.1016/s0140-6736(21)02724-0. ISSN 0140-6736. PMID 35065702. PMC 8841637. https://doi.org/10.1016/S0140-6736(21)02724-0. 
  17. ↑ 17.0 17.1 17.2 "Pass the PASTEUR Act Now | Fight Infectious Disease" (in en). https://www.fightinfectiousdisease.org/passpasteur. 
  18. ↑ "DISARM Act IDSA News Release". https://www.idsociety.org/news--publications-new/articles/2019/disarm-act-provides-framework-needed-to-spur-antibiotic-rd-protect-existing-drugs/. 
  19. ↑ "DISARM Act Letter of Support". https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Advocacy/Final-S-FAR-DISARM-Letter.pdf. 
  20. ↑ "Strategies to Address Antimicrobial Resistance (STAAR) Act". https://www.idsociety.org/globalassets/idsa/topics-of-interest/antimicrobial-resistance/staar-themes-one-pager.pdf. 
  21. ↑ 21.0 21.1 "BIO Preparedness Workforce Act" (in en). https://www.idsociety.org/policy--advocacy/bio-preparedness-workforce-pilot/. 
  22. ↑ Cosgrove, SE (December 2014). "Guidance for the knowledge and skills required for antimicrobial stewardship leaders". Infect Control Hosp Epidemiol 35 (12): 1444–51. doi:10.1086/678592. PMID 25419765. 
  23. ↑ Heil, EL (July 2016). "The Essential Role of Pharmacists in Antimicrobial Stewardship". Infect Control Hosp Epidemiol 37 (7): 753–754. doi:10.1017/ice.2016.82. PMID 27072411. 
  24. ↑ "COVID-19 Guideline, Part 1: Treatment and Management" (in en). 2022. https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/. 
  25. ↑ Tsuji, BT (January 2019). "International Consensus Guidelines for the Optimal Use of the Polymyxins". Pharmacotherapy 39 (1): 10–39. doi:10.1002/phar.2209. PMID 30710469. 
  26. ↑ Aitken, SL (April 2016). "Agricultural Applications for Antimicrobials. A Danger to Human Health: An Official Position Statement of the Society of Infectious Diseases Pharmacists". Pharmacotherapy 36 (4): 422–432. doi:10.1002/phar.1737. PMID 26954889. 
  27. ↑ Klepser, ME (August 2017). "A call to action for outpatient antibiotic stewardship". Journal of the American Pharmacists Association 57 (4): 457–463. doi:10.1016/j.japh.2017.03.013. PMID 28499717. https://www.japha.org/article/S1544-3191(17)30145-0/abstract. 
  28. ↑ "SIDP Annual Meeting". https://www.sidp.org/2019AnnualMeeting. 
  29. ↑ "IDWeek Conference". https://idweek.org/. 
  30. ↑ "IDSA News Release: Society of Infectious Diseases Pharmacists Joins IDWeek". https://www.idsociety.org/news--publications-new/articles/2019/society-of-infectious-diseases-pharmacists-joins-idweektm/. 
  31. ↑ "SIDP - SIDP Education Center". https://sidp.org/SIDPEC. 
  32. ↑ "SIDP - Grants". https://sidp.org/Grants. 
  33. ↑ "Recertification Guide" (in en-US). https://www.bpsweb.org/recertification/recertification-guide/. 
  34. ↑ "SIDP - ID Pharmacists and Antibiotics". https://www.sidp.org/ID-Pharmacists-Antibiotics. 

External links



Retrieved from "https://handwiki.org/wiki/index.php?title=Organization:Society_of_Infectious_Diseases_Pharmacists&oldid=3397487"